HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Industry Groups Keeping Eye On Montana’s Fragrance-Disclosure Bill

This article was originally published in The Rose Sheet

Executive Summary

The International Fragrance Association North America and Personal Care Products Council are monitoring state-level proposals in the US to require full fragrance ingredient disclosure, including a Montana bill that passed committee in February. IFRA NA head Farah Ahmed discusses the group’s related advocacy work.

You may also be interested in...

Fragrance Secrets Remain Safe For Now, But State Disclosure Efforts Continue

Some fragrance-disclosure bills of concern to cosmetics industry stakeholders languished in state legislative sessions this year, but others remain under consideration – in Minnesota and North Carolina, for example. IFRA North America maintains that forced disclosure of fragrance ingredients could have unintended negative consequences.

California Cleaning Products Bill Adds To ‘Right To Know’ Momentum

Fragrance trade secrets are under attack on multiple fronts, including in California under the proposed Cleaning Product Right to Know Act. The proposal adds to momentum behind initiatives to improve transparency around ingredient use in cosmetics, home-care and other consumer product categories.

Unilever Commits To Personal-Care Fragrance Disclosure; Who’s Next?

Unilever’s announcement that it will disclose fragrance ingredients in personal-care products is a potential game-changer for the industry, representing a heretofore unseen level of transparency from a leading multinational.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts